BALDUZZI ADRIANA CRISTINA

Peccatori, N., Curto, A., Silvestri, D., Rebellato, S., Antic, Z., Bhatia, S., et al. (2026). PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE. HAEMATOLOGICA, 111(1), 1-1 [10.3324/haematol.2026.s1.54]. Dettaglio

Willasch, A., Horgan, C., Peters, C., Balduzzi, A., Dalle, J., Zecca, M., et al. (2026). Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP. BONE MARROW TRANSPLANTATION, 61(1), 67-74 [10.1038/s41409-025-02734-8]. Dettaglio

Neu, M., Ortmuller, F., Robinson, A., Dreismickenbecker, E., Otto, H., Wypyrsczyk, L., et al. (2026). The mainz resilience assessment in childhood cancer (MRAcc): development of a novel age-specific patient-reported outcome measure to assess resilience in childhood cancer patients. BMC CANCER, 26(1) [10.1186/s12885-026-15776-y]. Dettaglio

Alt, F., Dreismickenbecker, E., Lanfranconi, F., Balduzzi, A., Watson, E., Marriott, H., et al. (2026). Navigating ethical challenges in the FORTEe randomised controlled trial: a multi-centre staff survey on exercise intervention for children and adolescents undergoing cancer treatment. BMC MEDICAL ETHICS, 27(1) [10.1186/s12910-026-01414-6]. Dettaglio

Balduzzi, A., Glogova, E., Peters, C., Sedlacek, P., Dalle, J., Locatelli, F., et al. (2026). Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial. HAEMATOLOGICA, 111(1 (January, 2026)), 122-134 [10.3324/haematol.2025.287456]. Dettaglio